Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.

 
Web www.patentalert.com

< Methods for modulating eicosanoid metabolism

> Method for detecting activated CD3+ T-cells

> Pyridazine derivatives

~ 00534